Targeting the gut microbiome: An emerging trend in hematopoietic stem cell transplantation

Blood Reviews ◽  
2020 ◽  
pp. 100790
Author(s):  
Sona Ciernikova ◽  
Barbora Kasperova ◽  
Lubos Drgona ◽  
Bozena Smolkova ◽  
Viola Stevurkova ◽  
...  
2020 ◽  
Vol 67 (12) ◽  
Author(s):  
Riccardo Masetti ◽  
Daniele Zama ◽  
Davide Leardini ◽  
Edoardo Muratore ◽  
Silvia Turroni ◽  
...  

2021 ◽  
Vol 22 (3) ◽  
pp. 1197
Author(s):  
Riccardo Masetti ◽  
Daniele Zama ◽  
Davide Leardini ◽  
Edoardo Muratore ◽  
Silvia Turroni ◽  
...  

The gut microbiome has emerged as a major character in the context of hematopoietic stem cell transplantation. The biology underpinning this relationship is still to be defined. Recently, mounting evidence has suggested a role for microbiome-derived metabolites in mediating crosstalk between intestinal microbial communities and the host. Some of these metabolites, such as fiber-derived short-chain fatty acids or amino acid-derived compounds, were found to have a role also in the transplant setting. New interesting data have been published on this topic, posing a new intriguing perspective on comprehension and treatment. This review provides an updated comprehensive overview of the available evidence in the field of gut microbiome-derived metabolites and hematopoietic stem cell transplantation.


2021 ◽  
Vol 11 (1) ◽  
Author(s):  
Riccardo Masetti ◽  
Elena Biagi ◽  
Daniele Zama ◽  
Edoardo Muratore ◽  
Federica D’Amico ◽  
...  

AbstractHepatic sinusoidal obstruction syndrome (SOS/VOD) represents a dramatic complication of hematopoietic stem cell transplantation (HSCT), particularly in children. Recent evidence has suggested a role for the gut microbiome (GM) in the context of HSCT and its related complications, but no data are available on the relationship between GM and SOS/VOD. Here, we conducted a retrospective case–control study in allo-HSCT pediatric patients developing or not SOS/VOD and profiled their GM over time, from before the transplant up to 72 days after. A rich and diverse GM before HSCT was found to be associated with a reduced likelihood of developing SOS/VOD. Furthermore, prior to transplant, patients not developing SOS/VOD showed an enrichment in some typically health-associated commensals, such as Bacteroides, Ruminococcaceae and Lachnospiraceae. Their levels remained overall higher until post-transplant. This high-diversity configuration resembles that described in other studies for other HSCT-related complications, including graft-versus-host disease, potentially representing a common protective GM feature against HSCT complications.


Sign in / Sign up

Export Citation Format

Share Document